We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$5.05M
Cap. Flow
-$2.11M
Cap. Flow %
-1.43%
Top 10 Hldgs %
70.99%
Holding
52
New
–
Increased
25
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
UMH
UMH Properties
UMH
+$2.52M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
3
AGN
Allergan plc
AGN
+$832K
4
JNJ icon
Johnson & Johnson
JNJ
+$789K
5
MNR
Monmouth Real Estate Investment Corp
MNR
+$742K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.05M
2
BIIB icon
Biogen
BIIB
+$1.77M
3
NNN icon
NNN REIT
NNN
+$1.58M
4
LSBG
Lake Sunapee Bank Group
LSBG
+$1.07M
5
HSY icon
Hershey
HSY
+$490K

Sector Composition

Rank Sector Weight
1 Real Estate 36.46%
2 Healthcare 22.51%
3 Consumer Staples 8.81%
4 Consumer Discretionary 6.09%
5 Technology 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNR
1
DELISTED
Monmouth Real Estate Investment Corp
MNR
$29.8M 20.24%
2,243,831
+61,346
+3% +$742K
UMH
2
UMH Properties
UMH
$1.32B
$14.5M 9.84%
1,285,191
+248,865
+24% +$2.52M
JNJ icon
3
Johnson & Johnson
JNJ
$635B
$12.7M 8.64%
104,743
+6,943
+7% +$789K
PEP icon
4
PepsiCo
PEP
$186B
$9.76M 6.64%
92,086
+3,853
+4% +$398K
HD icon
5
Home Depot
HD
$332B
$8.12M 5.53%
63,605
+794
+1% +$105K
NNN icon
6
NNN REIT
NNN
$9.39B
$6.94M 4.72%
134,119
-34,028
-20% -$1.58M
AGN
7
DELISTED
Allergan plc
AGN
$6.2M 4.22%
26,809
+3,609
+16% +$832K
GILD icon
8
Gilead Sciences
GILD
$161B
$6.12M 4.16%
73,361
+235
+0.3% +$20.9K
AAPL icon
9
Apple
AAPL
$4.89T
$5.69M 3.87%
238,080
-5,636
-2% -$140K
DIS icon
10
Walt Disney
DIS
$165B
$4.6M 3.13%
47,060
-395
-0.8% -$39.5K
TYG
11
Tortoise Energy Infrastructure Corp
TYG
$1.14B
$3.41M 2.32%
27,662
+632
+2% +$72K
HSY icon
12
Hershey
HSY
$35.4B
$3.2M 2.17%
28,165
-5,230
-16% -$490K
HON icon
13
Honeywell
HON
$77.1B
$2.69M 1.83%
25,745
-578
-2% -$59.4K
WFC icon
14
Wells Fargo
WFC
$261B
$2.47M 1.68%
52,221
-1,614
-3% -$78.7K
SIR
15
DELISTED
SELECT INCOME REIT
SIR
$2.44M 1.66%
213,361
+9,942
+5% +$106K
NVS icon
16
Novartis
NVS
$295B
$2.24M 1.53%
30,345
-29,663
-49% -$2.05M
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
$1.96M 1.34%
23,576
+1
+0% +$81
MPC icon
18
Marathon Petroleum
MPC
$90.3B
$1.84M 1.25%
48,471
+215
+0.4% +$7.9K
JPM icon
19
JPMorgan Chase
JPM
$939B
$1.79M 1.22%
28,850
-150
-0.5% -$9.37K
TPZ
20
Tortoise Electrification Infrastructure ETF
TPZ
$132M
$1.68M 1.14%
85,971
+1,781
+2% +$33.2K
MA icon
21
Mastercard
MA
$477B
$1.64M 1.11%
18,604
-949
-5% -$90.6K
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
$1.61M 1.1%
91,770
-4,625
-5% -$74.9K
PPG icon
23
PPG Industries
PPG
$25.9B
$1.55M 1.05%
14,873
-2,980
-17% -$325K
BMY icon
24
Bristol-Myers Squibb
BMY
$127B
$1.39M 0.95%
18,885
+14,615
+342% +$1.03M
OPK icon
25
Opko Health
OPK
$921M
$1.11M 0.76%
119,225
+4,605
+4% +$46.8K
1
2 3

Similar funds

ACM
AidennLair Capital Management New York $200M AUM 4.39% 1-Year Est. Return
SSM
Sutton Square Management New York $193M AUM
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
ESG
Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Boulegeris Investments's Q2 2016 Portfolio in Review

As of Q2 2016, Boulegeris Investments held 52 positions worth $147M, up 3.6% from $142M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Boulegeris Investments's Q2 2016 filing shows 25 increased, 18 reduced and 7 closed positions. The largest sale was Novartis, an estimated $2.05M.

By sector, the portfolio is most concentrated in Real Estate at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boulegeris Investments added most to UMH Properties in Q2 2016, an estimated $2.52M increase.
  • Boulegeris Investments's biggest Q2 2016 reduction was Novartis, cutting an estimated $2.05M.
  • Boulegeris Investments fully exited Biogen in Q2 2016, selling an estimated $1.77M.
  • Boulegeris Investments's ten largest holdings make up 71% of its $147M portfolio in Q2 2016.
  • Boulegeris Investments opened 0 new positions and closed 7 in Q2 2016.
  • Boulegeris Investments's portfolio value rose 3.6% quarter-over-quarter to $147M.

Based on Boulegeris Investments's 13F filing for Q2 2016, filed 12 Jul 2016.